GlassScriptPhysician profile
Paul L Lin
NPI 1497722714
$10,034.21
in general payments reported to CMS, 2019-2025
41 companies · $739 in 2025
The $739 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,510 · 2020: $661 · 2021: $1,959 · 2022: $2,689 · 2023: $1,138 · 2024: $1,339 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,143 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,142.81 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,868.28 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Abbvie INC. | $1,135.22 | 2019-2024 | |
| Avanos Medical | $1,043.93 | 2019-2024 | On-Q* Pump and Accessories |
| Mayne Pharma Commercial LLC | $846.76 | 2021-2025 | |
| Daiichi Sankyo INC. | $612.96 | 2019-2022 | |
| Amgen INC. | $557.99 | 2019-2024 | Evenity, Prolia |
| Lupin INC. | $445.15 | 2019-2021 | |
| Pfizer INC. | $402.03 | 2022-2025 | |
| Astellas Pharma US INC | $381.53 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $375.48 | 2021-2025 | Slynd |
| Shield Therapeutics INC | $273.56 | 2022-2025 | |
| Evofem Biosciences, INC. | $227.07 | 2020-2023 | Phexxi |
| Avion Pharmaceuticals | $190.47 | 2020-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $186.71 | 2021-2025 | |
| Organon LLC | $178.31 | 2021-2024 | Nexplanon |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.